Objective This study was conducted to explore the application of age-male-ALBI-platelets
(aMAP) score for predicting late recurrence of hepatocellular carcinoma (HCC) following …

Background Radiofrequency ablation (RFA) is one of the primary treatment methods for T1/2
hepatocellular carcinoma (HCC), but the risk factors after RFA remain controversial. This …

Simple Summary Radiofrequency ablation is a curative treatment for early-stage
hepatocellular carcinoma (HCC), but many factors influence the survival of these patients …

Background Radiofrequency ablation (RFA) is an effective treatment option for
hepatocellular carcinoma (HCC). This study aimed to analyze the prognostic factors of HCC …

Background Our study aimed to explore the prognostic value of the aspartate
aminotransferase–platelet ratio index (APRI) and to develop a new nomogram for patients …

Background There are large variations in prognosis among hepatocellular carcinoma (HCC)
patients undergoing radiofrequency ablation (RFA). However, current staging or scoring …

Simple Summary Early detection and treatment of recurrence after radiofrequency ablation
(RFA) for hepatocellular carcinoma (HCC) are important steps to improving patient survival …

Background Long-term survivals of patients with HBV-related hepatocellular carcinoma are
limited by the high incidence of tumor recurrence after radiofrequency ablation (RFA) …

Objective The purpose of this study was to construct nomograms for the disease-free
survival (DFS) and overall survival (OS) of post-radiofrequency ablation (RFA) patients with …

Background: Hepatocellular carcinoma (HCC) patients have a poor prognosis after radio-
frequency ablation (RFA), and investigating the risk factors affecting RFA and establishing …